This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Fundacio Institut Catala D'investigacio Quimica, The United States of America, as Represented by the Secretary, Department of Health and Human Services, Universitat Rovira I Virgili. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3 
1 out of 3,697 
1 out of 12 
Years Active: 2021
Title: Zhenhua Wu: Innovator in Cancer Treatment
Introduction
Zhenhua Wu is a notable inventor based in Newark, DE (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds. His work focuses on creating effective treatments for various types of cancer, particularly renal cancer.
Latest Patents
Zhenhua Wu holds a patent for "Englerin derivatives for treatment of cancer." This patent discloses a compound of formula (I), where specific variables are defined in the documentation. The patent also includes a pharmaceutical composition containing the compound and outlines a method for using it to treat cancer.
Career Highlights
Throughout his career, Zhenhua Wu has worked with prestigious organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services, and the Fundació Institut Català d'Investigació Química. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Zhenhua Wu has collaborated with esteemed colleagues such as John A. Beutler and Antonio Echavarren. These partnerships have further enriched his research and development efforts in the field of cancer treatment.
Conclusion
Zhenhua Wu's innovative work in developing compounds for cancer treatment highlights his dedication to improving healthcare outcomes. His contributions to the field are invaluable and continue to inspire future research in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile